Very low-risk versus low-risk prostate cancer: A distinction worth keeping

被引：0
作者：
Epstein, Jonathan I. [1 ]
机构：
[1] Johns Hopkins Med Inst, 401N Broadway St,RM 2242, Baltimore, MD 21278 USA
来源：
PROSTATE | 2021年 / 81卷 / 13期
关键词：
ACTIVE-SURVEILLANCE; RADICAL PROSTATECTOMY; DISCONTINUOUS FOCI; OUTCOMES; INVOLVEMENT; CORE; MEN;
D O I：
10.1002/pros.24197
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：923 / 925
页数：3
相关论文
共 16 条
  • [1] Arias-Stella JA, 2015, AM J SURG PATHOL, V39, P281, DOI 10.1097/PAS.0000000000000344
  • [2] Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Schultz, D
    Blank, K
    Broderick, GA
    Tomaszewski, JE
    Renshaw, AA
    Kaplan, I
    Beard, CJ
    Wein, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11): : 969 - 974
  • [3] PATHOLOGICAL AND CLINICAL FINDINGS TO PREDICT TUMOR EXTENT OF NONPALPABLE (STAGE-T1C) PROSTATE-CANCER
    EPSTEIN, JI
    WALSH, PC
    CARMICHAEL, M
    BRENDLER, CB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (05): : 368 - 374
  • [4] The end of "very low risk" in localized prostate cancer?
    Ferraris, Federico
    Yaber, Fabian
    Smith, Angela B.
    Barreiro, Diego
    [J]. PROSTATE, 2021, 81 (10) : 615 - 617
  • [5] Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry
    Fontugne, Jacqueline
    Davis, Kristina
    Palanisamy, Nallasivam
    Udager, Aaron
    Mehra, Rohit
    McDaniel, Andrew S.
    Siddiqui, Javed
    Rubin, Mark A.
    Mosquera, Juan Miguel
    Tomlins, Scott A.
    [J]. MODERN PATHOLOGY, 2016, 29 (02) : 157 - 165
  • [6] Long-term Results of Active Surveillance in the Goteborg Randomized, Population-based Prostate Cancer Screening Trial
    Godtman, Rebecka Arnsrud
    Holmberg, Erik
    Khatami, Ali
    Pihl, Carl-Gustaf
    Stranne, Johan
    Hugosson, Jonas
    [J]. EUROPEAN UROLOGY, 2016, 70 (05) : 760 - 766
  • [7] Should Intervening Benign Tissue Be Included in the Measurement of Discontinuous Foci of Cancer on Prostate Needle Biopsy? Correlation With Radical Prostatectomy Findings
    Karram, Sarah
    Trock, Bruce J.
    Netto, George J.
    Epstein, Jonathan I.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (09) : 1351 - 1355
  • [8] Long-Term Outcomes of Partial Prostate Treatment With Magnetic Resonance Imaging-Guided Brachytherapy for Patients With Favorable-Risk Prostate Cancer
    King, Martin T.
    Nguyen, Paul L.
    Boldbaatar, Ninjin
    Tempany, Clare M.
    Cormack, Robert A.
    Beard, Clair J.
    Hurwitz, Mark D.
    Suh, W. Warren
    D'Amico, Anthony V.
    Orio, Peter F., III
    [J]. CANCER, 2018, 124 (17) : 3528 - 3535
  • [9] Biopsy Criteria for Determining Appropriateness for Active Surveillance in the Modern Era
    Kryvenko, Oleksandr N.
    Carter, H. Ballentine
    Trock, Bruce J.
    Epstein, Jonathan I.
    [J]. UROLOGY, 2014, 83 (04) : 869 - 874
  • [10] 17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort
    Lin, Daniel W.
    Zheng, Yingye
    McKenney, Jesse K.
    Brown, Marshall D.
    Lu, Ruixiao
    Crager, Michael
    Boyer, Hilary
    Tretiakova, Maria
    Brooks, James D.
    Dash, Atreya
    Fabrizio, Michael D.
    Gleave, Martin E.
    Kolb, Suzanne
    Liss, Michael
    Morgan, Todd M.
    Thompson, Ian M.
    Wagner, Andrew A.
    Tsiatis, Athanasios
    Pingitore, Andrea
    Nelson, Peter S.
    Newcomb, Lisa F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (14) : 1549 - +
12